| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ed96cc1bf39d788dd2d9e296f1be09fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_661c68977a99ccd5a68ea29d1b870a1b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e8194e40c72452a9e5511ae44e58314d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c89ce4d9ac03f9acd8ddede1162f94d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517 |
| filingDate |
2010-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2014-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c1d4ed62955d08e5dcfac657be6d0f3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5433286c42ae6e40620c371e9c8d756
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13e32e3cc58ccc3536d27908a4a52a43 |
| publicationDate |
2014-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8664387-B2 |
| titleOfInvention |
Pyridoquinazolinone M1 receptor positive allosteric modulators |
| abstract |
The present invention is directed to quinolinone-pyrazolone compounds of formula (I) which are M1 receptor positive allosteric modulators and that are useful in the treatment of diseases in which the M1 receptor is involved, such as Alzheimer's disease, schizophrenia, pain or sleep disorders. The invention is also directed to pharmaceutical compositions comprising the compounds, and to the use of the compounds and compositions in the treatment of diseases mediated by the M1 receptor. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9284312-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015141444-A1 |
| priorityDate |
2009-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |